MIDLAND MEMORIAL HOSPITAL
- Type
- Teaching hospital
- Where
- Midland, TX
- Medicare CCN
- 450133
- Received
- $77,400 in 121 records, 2019 ($31,993 general, $45,407 research)
- Source
- CMS Open Payments search ↗
On this site
- Nonprofit contractor: MIDLAND MEMORIAL HOSPITAL Fuzzy (name and state)
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2019 | General payment | 10 | $31,993 |
| 2019 | Research payment | 111 | $45,407 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Incyte Corporation | 111 | $45,407 | 2019 |
| Vitalant | 3 | $17,622 | 2019 |
| Barco, Inc. | 1 | $6,221 | 2019 |
| Intuitive Surgical, Inc. | 2 | $5,520 | 2019 |
| ALLEN MEDICAL SYSTEMS | 1 | $1,468 | 2019 |
| Linvatec Corporation | 1 | $1,050 | 2019 |
| Masimo Corporation | 2 | $112 | 2019 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 111 | $45,407 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 3 | $17,622 |
| Gift | 4 | $13,209 |
| Grant | 1 | $1,050 |
| Education | 2 | $112 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2019-12-31 | Masimo Corporation | $74 | Education | In-kind items and services | SedLine Device, Devices | 2019 | |
| 2019-12-31 | Masimo Corporation | $37 | Education | In-kind items and services | SedLine Device, Devices | 2019 | |
| 2019-12-15 | Incyte Corporation | $489 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-12-15 | Incyte Corporation | $105 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-12-09 | Incyte Corporation | $57 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-12-09 | Incyte Corporation | $54 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-12-09 | Incyte Corporation | $0 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-12-09 | Incyte Corporation | $0 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-12-05 | Incyte Corporation | $2,869 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-11-22 | Vitalant | $5,607 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-11-15 | Incyte Corporation | $489 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-11-15 | Incyte Corporation | $105 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-11-08 | Incyte Corporation | $176 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-11-08 | Incyte Corporation | $87 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-11-08 | Incyte Corporation | $76 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-11-08 | Incyte Corporation | $45 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-11-08 | Incyte Corporation | $22 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-11-08 | Incyte Corporation | $22 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-11-08 | Incyte Corporation | $1 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-11-08 | Incyte Corporation | $0 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-10-15 | Incyte Corporation | $850 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-10-15 | Incyte Corporation | $489 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-10-15 | Incyte Corporation | $489 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-10-15 | Incyte Corporation | $489 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-10-15 | Incyte Corporation | $489 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-10-15 | Incyte Corporation | $489 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-10-15 | Incyte Corporation | $489 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-10-15 | Incyte Corporation | $489 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-10-15 | Incyte Corporation | $489 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-10-15 | Incyte Corporation | $105 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-10-15 | Incyte Corporation | $105 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-10-15 | Incyte Corporation | $105 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-10-09 | Incyte Corporation | $573 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-09-19 | Vitalant | $4,183 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-09-15 | Incyte Corporation | $489 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-09-15 | Incyte Corporation | $105 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-09-13 | Incyte Corporation | $6,426 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-08-15 | Vitalant | $7,832 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v (2 payments) | Cash or cash equivalent | 2019 | ||
| 2019-08-15 | Incyte Corporation | $489 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-08-15 | Incyte Corporation | $489 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-08-15 | Incyte Corporation | $489 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-08-15 | Incyte Corporation | $105 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-08-15 | Incyte Corporation | $105 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-08-15 | Incyte Corporation | $105 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-07-17 | Incyte Corporation | $9,182 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-07-15 | Incyte Corporation | $850 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-07-15 | Incyte Corporation | $489 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-07-15 | Incyte Corporation | $489 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-07-15 | Incyte Corporation | $105 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-07-15 | Incyte Corporation | $105 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-07-10 | Incyte Corporation | $32 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-07-10 | Incyte Corporation | $22 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-06-24 | Barco, Inc. | $6,221 | Gift | In-kind items and services | COR C F 6MP 30"1H1F 5X00 Device, Diagnostic Imaging | 2019 | |
| 2019-06-15 | Incyte Corporation | $489 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-06-15 | Incyte Corporation | $489 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-06-15 | Incyte Corporation | $489 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-06-15 | Incyte Corporation | $489 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-06-15 | Incyte Corporation | $489 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-06-15 | Incyte Corporation | $105 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-06-15 | Incyte Corporation | $105 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-06-15 | Incyte Corporation | $105 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-06-15 | Incyte Corporation | $105 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-06-10 | Incyte Corporation | $68 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-06-10 | Incyte Corporation | $0 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-05-15 | Incyte Corporation | $489 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-05-15 | Incyte Corporation | $489 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-05-15 | Incyte Corporation | $105 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-05-15 | Incyte Corporation | $105 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-05-11 | Incyte Corporation | $35 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-05-11 | Incyte Corporation | $14 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-05-10 | Incyte Corporation | $157 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-05-10 | Incyte Corporation | $33 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-05-09 | Incyte Corporation | $585 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-05-09 | Incyte Corporation | $157 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-05-09 | Incyte Corporation | $125 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-05-09 | Incyte Corporation | $50 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-05-09 | Incyte Corporation | $50 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-05-09 | Incyte Corporation | $24 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-05-09 | Incyte Corporation | $24 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-05-09 | Incyte Corporation | $23 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-05-09 | Incyte Corporation | $10 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-05-09 | Incyte Corporation | $10 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-05-08 | Incyte Corporation | $220 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-05-08 | Incyte Corporation | $114 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-05-08 | Incyte Corporation | $87 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-05-08 | Incyte Corporation | $57 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-05-08 | Incyte Corporation | $34 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-05-08 | Incyte Corporation | $1 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-05-08 | Incyte Corporation | $0 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-04-15 | Incyte Corporation | $850 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-04-15 | Incyte Corporation | $489 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-04-15 | Incyte Corporation | $105 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-03-19 | ALLEN MEDICAL SYSTEMS | $1,468 | Gift | Cash or cash equivalent | 2019 | ||
| 2019-03-18 | Intuitive Surgical, Inc. | $2,760 | Gift | In-kind items and services | Da Vinci Surgical System Device, SURGERY | 2019 | |
| 2019-03-18 | Intuitive Surgical, Inc. | $2,760 | Gift | In-kind items and services | Da Vinci Surgical System Device, SURGERY | 2019 | |
| 2019-03-15 | Incyte Corporation | $489 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-03-15 | Incyte Corporation | $489 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-03-15 | Incyte Corporation | $489 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-03-15 | Incyte Corporation | $489 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-03-15 | Incyte Corporation | $489 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-03-15 | Incyte Corporation | $489 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-03-15 | Incyte Corporation | $105 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-03-15 | Incyte Corporation | $105 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-03-08 | Incyte Corporation | $176 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-03-08 | Incyte Corporation | $98 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-03-08 | Incyte Corporation | $91 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-03-08 | Incyte Corporation | $57 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-03-08 | Incyte Corporation | $22 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-03-08 | Incyte Corporation | $2 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-03-08 | Incyte Corporation | $0 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-03-05 | Linvatec Corporation | $1,050 | Grant | In-kind items and services | IFS Device, GENERAL SURGERY | 2019 | |
| 2019-02-15 | Incyte Corporation | $489 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-02-15 | Incyte Corporation | $489 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-02-15 | Incyte Corporation | $489 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-02-15 | Incyte Corporation | $489 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-02-15 | Incyte Corporation | $105 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-02-15 | Incyte Corporation | $105 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-01-15 | Incyte Corporation | $850 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-01-15 | Incyte Corporation | $489 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-01-15 | Incyte Corporation | $489 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-01-15 | Incyte Corporation | $105 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Midland, TX, county Midland County, TX, state Texas; placed by its city name.
| Measure | Place (city or town) Midland, TX | County Midland County, TX | State Texas |
|---|---|---|---|
| Population B01003 | 136,640 | 174,801 | 30,188,424 |
| Population, 2020 census P1 | 132,524 | 169,983 | 29,145,505 |
| Median age B01002 | 31.5 | 32.8 | 35.6 |
| Under 18 B01001 | 29.8% | 29.1% | 25.0% |
| 65 and over B01001 | 10.1% | 10.7% | 13.4% |
| Households B11001 | 53,414 | 67,651 | 10,992,816 |
| Foreign born B05002 | 13.2% | 12.8% | 17.6% |
| Median household income B19013 | $89,585 | $92,874 | $78,476 |
| Median family income B19113 | $111,352 | $111,503 | $94,599 |
| Per capita income B19301 | $49,879 | $49,746 | $40,752 |
| Poverty rate B17001 | 12.4% | 11.3% | 13.8% |
| Unemployment rate B23025 | 3.5% | 3.4% | 5.3% |
| Civilian labor force B23025 | 69,526 | 89,931 | 15,233,563 |
| Mean commute (minutes) B08013 | 20.1 | 21.7 | 26.7 |
| Bachelor's degree or higher B15003 | 33.7% | 31.0% | 33.8% |
| Housing units B25001 | 57,260 | 72,723 | 12,128,515 |
| Owner-occupied B25003 | 65.1% | 67.6% | 62.6% |
| Renters B25003 | 34.9% | 32.4% | 37.4% |
| Median home value B25077 | $319,200 | $312,700 | $283,800 |
| Median gross rent B25064 | $1,434 | $1,407 | $1,403 |
| White, not Hispanic B03002 | 41.3% | 42.3% | 39.1% |
| Black B03002 | 7.4% | 6.4% | 11.9% |
| Hispanic or Latino B03002 | 45.9% | 46.0% | 39.7% |
| Asian B03002 | 2.6% | 2.4% | 5.5% |
| American Indian and Alaska Native B03002 | 0.2% | 0.1% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Midland, TX.
Comments